Metraipolis › archive › dc_db76a27de220

Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal — Europe PMC PMID:17543114

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/17543114
DOI
10.1186/1743-8462-4-9
License (as archived)
solo-consultazione
Archived
2026-10-08T08:10:41.800Z
SHA-256 of the archived text
428d33199f293485549d5be55a593dad06abc89fd39a33075f1ebadc98803228
Stable URL of this page
https://metraipolis.com/documento/dc_db76a27de220

How to cite

Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal — Europe PMC PMID:17543114 — Europe PMC (en), https://europepmc.org/article/MED/17543114 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_db76a27de220 (Metraipolis archive dc_db76a27de220, sha256 428d33199f293485549d5be55a593dad06abc89fd39a33075f1ebadc98803228)
BibTeX
@misc{dcdb76a27de220,
  title = {Challenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewal — Europe PMC PMID:17543114},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/17543114},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_db76a27de220; sha256 428d33199f293485549d5be55a593dad06abc89fd39a33075f1ebadc98803228},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/17543114. Agents can read the archived copy with the MCP tool read_document.